Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 216 | $64,676,564 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 1 | 158.09 | 158 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 4 | 227.38 | 910 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 5 | 224 | 1,120 | D |
03 Feb 2023 17:46 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 02 Feb 2023 | Sale | 5 | 227.38 | 1,137 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2024 | Sale | 8 | 158.09 | 1,265 | D |
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 9 | 157.3 | 1,416 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 9 | 224.17 | 2,018 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 14 | 157.3 | 2,202 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 17 | 157.3 | 2,674 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 17 | 157.3 | 2,674 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 15 | 188.4 | 2,826 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 15 | 188.4 | 2,826 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 13 | 225.55 | 2,932 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 04 Aug 2023 | Sale | 17 | 188.4 | 3,203 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 04 Aug 2023 | Sale | 17 | 188.4 | 3,203 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 17 | 224.17 | 3,811 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 24 | 225.55 | 5,413 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 26 | 226.82 | 5,897 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 42 | 195.65 | 8,217 | D |
31 May 2024 19:00 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SCHULMAN AMY W | Director | 29 May 2024 | Sale | 63 | 149.76 | 9,435 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 45 | 221.71 | 9,977 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 45 | 226.82 | 10,207 | D |
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 66 | 156.38 | 10,321 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 27 Apr 2023 | Sale | 64 | 195.65 | 12,522 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 28 Feb 2024 | Sale | 84 | 157.3 | 13,213 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 68 | 197.08 | 13,401 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 66 | 224.17 | 14,795 | D |
01 Mar 2024 16:12 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 29 Feb 2024 | Sale | 101 | 154.07 | 15,561 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 100 | 156.38 | 15,638 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 27 Apr 2023 | Sale | 81 | 193.18 | 15,648 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 80 | 195.65 | 15,652 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 86 | 187.37 | 16,114 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 86 | 187.37 | 16,114 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 02 Feb 2023 | Sale | 73 | 223.97 | 16,350 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 74 | 231.59 | 17,138 | D |
03 Feb 2023 17:46 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 02 Feb 2023 | Sale | 77 | 223.97 | 17,246 | D |
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 111 | 155.45 | 17,255 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 78 | 221.71 | 17,293 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 16 Feb 2024 | Sale | 120 | 149.03 | 17,884 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 115 | 156.38 | 17,984 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 115 | 156.38 | 17,984 | D |
20 Feb 2024 16:08 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 16 Feb 2024 | Sale | 121 | 149.03 | 18,033 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 93 | 201.3 | 18,721 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 04 Aug 2023 | Sale | 101 | 187.37 | 18,924 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 04 Aug 2023 | Sale | 101 | 187.37 | 18,924 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 86 | 233.53 | 20,084 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 103 | 196.62 | 20,252 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 27 Apr 2023 | Sale | 103 | 197.08 | 20,299 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 27 Apr 2023 | Sale | 104 | 195.65 | 20,348 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 93 | 225.55 | 20,976 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 99 | 219.53 | 21,733 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 96 | 228.3 | 21,917 | D |
29 Feb 2024 16:16 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FRANCHINI INDRANI LALL | EVP, CLO & Secretary | 28 Feb 2024 | Sale | 142 | 154.54 | 21,945 | D |
17 Aug 2022 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 15 Aug 2022 | Sale | 98 | 226.16 | 22,164 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 99 | 231.59 | 22,927 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 99 | 231.59 | 22,927 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 105 | 220.95 | 23,200 | D |
20 Feb 2024 16:09 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 16 Feb 2024 | Sale | 156 | 149.03 | 23,249 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 104 | 225.15 | 23,416 | D |
28 Apr 2023 17:55 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 27 Apr 2023 | Sale | 122 | 193.18 | 23,568 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 129 | 197.08 | 25,423 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 170 | 155.45 | 26,426 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 115 | 233.53 | 26,856 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 115 | 233.53 | 26,856 | D |
03 Feb 2023 17:45 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Feb 2023 | Sale | 128 | 227.68 | 29,143 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 27 Apr 2023 | Sale | 151 | 193.18 | 29,170 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 125 | 235.19 | 29,399 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 129 | 228.3 | 29,451 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 129 | 228.3 | 29,451 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 129 | 231.59 | 29,875 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 194 | 155.45 | 30,157 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 194 | 155.45 | 30,157 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 04 Aug 2023 | Sale | 164 | 189.31 | 31,047 | D |
07 Aug 2023 18:05 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 04 Aug 2023 | Sale | 164 | 189.31 | 31,047 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 149 | 215.03 | 32,039 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 138 | 234.66 | 32,383 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 27 Apr 2023 | Sale | 168 | 197.08 | 33,109 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 28 Feb 2024 | Sale | 216 | 154.54 | 33,381 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 151 | 233.53 | 35,263 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 04 Aug 2023 | Sale | 192 | 189.31 | 36,348 | D |
07 Aug 2023 18:04 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 04 Aug 2023 | Sale | 192 | 189.31 | 36,348 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 161 | 232.54 | 37,439 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | VAISHNAW AKSHAY | President | 27 Apr 2023 | Sale | 197 | 193.18 | 38,056 | D |
29 Feb 2024 16:18 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 28 Feb 2024 | Sale | 247 | 154.54 | 38,171 | D |
29 Feb 2024 16:17 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Feb 2024 | Sale | 247 | 154.54 | 38,171 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 169 | 228.3 | 38,583 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 167 | 235.19 | 39,277 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 167 | 235.19 | 39,277 | D |
28 Apr 2023 17:54 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 28 Apr 2023 | Sale | 204 | 195.46 | 39,874 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)